Abstract
A growing list of membrane-spanning proteins involved in the transport of a large variety of drugs has been recognized and characterized to include peptide and organic anion/cation transporters. Given such an important role of transporter genes in drug disposition process, the role of single-nucleotide polymorphisms (SNPs) in such transporters as potential determinants of interindividual variability in drug disposition and pharmacological response has been investigated. To define the distribution of transporter gene SNPs across ethnic groups, we screened 450 DNAs in cohorts of 250 Korean, 50 Han Chinese, 50 Japanese, 50 African-American and 50 European-American ancestries for 64 SNPs in four transporter genes encoding proteins of the solute carrier family (SLC15A2, SLC22A1, SLC22A2 and SLC22A6). Of the 64 SNPs, 19 were core pharmacogenetic variants and 45 were HapMap tagging SNPs. Polymorphisms were genotyped using the golden gate genotyping assay. After genetic variability, haplotype structures and ethnic diversity were analyzed, we observed that the distributions of SNPs in a Korean population were similar to other Asian groups (Chinese and Japanese), and significantly different from African-American and European-American cohorts. Findings from this study would be valuable for further researches, including pharmacogenetic studies for drug responses.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Leabman, M. K., Huang, C. C., DeYoung, J., Carlson, E. J., Taylor, T. R., de la Cruz, M. et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc. Natl Acad. Sci. USA 100, 5896–5901 (2003).
Shu, Y., Sheardown, S. A., Brown, C., Owen, R. P., Zhang, S., Castro, R. A. et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Investig. 117, 1422–1431 (2007).
Adams, G. A. & Rose, J. K. Structural requirements of a membrane-spanning domain for protein anchoring and cell surface transport. Cell 41, 1007–1015 (1985).
Hediger, M. A., Romero, M. F., Peng, J. B., Rolfs, A., Takanaga, H. & Bruford, E. A. The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins. Introduction. Pflugers Arch. 447, 465–468 (2004).
Hooiveld, G. J., van Montfoort, J. E., Meijer, D. K. & Muller, M. Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport. Eur. J. Pharm. Sci. 12, 13–30 (2000).
Inui, K., Terada, T., Masuda, S. & Saito, H. Physiological and pharmacological implications of peptide transporters, PEPT1 and PEPT2. Nephrol Dial Transplant. 15 (Suppl 6), 11–13 (2000).
Inui, K. I., Masuda, S. & Saito, H. Cellular and molecular aspects of drug transport in the kidney. Kidney Int. 58, 944–958 (2000).
Pinsonneault, J., Nielsen, C. U. & Sadee, W. Genetic variants of the human H+/dipeptide transporter PEPT2: analysis of haplotype functions. J. Pharmacol. Exp. Ther. 311, 1088–1096 (2004).
Shu, Y., Brown, C., Castro, R. A., Shi, R. J., Lin, E. T., Owen, R. P. et al. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin. Pharmacol. Ther. 83, 273–280 (2008).
Becker, M. L., Visser, L. E., van Schaik, R. H., Hofman, A., Uitterlinden, A. G. & Stricker, B. H. Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J. 9, 242–247 (2009).
Song, I. S., Shin, H. J., Shim, E. J., Jung, I. S., Kim, W. Y., Shon, J. H. et al. Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin. Pharmacol. Ther. 84, 559–562 (2008).
Leabman, M. K., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E. et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 12, 395–405 (2002).
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H., Hosoyamada, M., Cha, S. H. et al. Characterization of methotrexate transport and its drug interactions with human organic anion transporters. J. Pharmacol. Exp. Ther. 302, 666–671 (2002).
Uwai, Y., Taniguchi, R., Motohashi, H., Saito, H., Okuda, M. & Inui, K. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3. Drug Metab. Pharmacokinet. 19, 369–374 (2004).
Bleasby, K., Hall, L. A., Perry, J. L., Mohrenweiser, H. W. & Pritchard, J. B. Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6). J Pharmacol Exp Ther. 314, 923–931 (2005).
Thompson, D., Stram, D., Goldgar, D. & Witte, J. S. Haplotype tagging single nucleotide polymorphisms and association studies. Hum. Hered. 56, 48–55 (2003).
Oliphant, A., Barker, D. L., Stuelpnagel, J. R. & Chee, M. S. BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. Biotechniques (Suppl), 56–58, 60–61 (2002).
Kang, H. J., Song, I. S., Shin, H. J., Kim, W. Y., Lee, C. H., Shim, J. C. et al. Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population. Drug Metab. Dispos. 35, 667–675 (2007).
Fujita, T., Brown, C., Carlson, E. J., Taylor, T., de la Cruz, M., Johns, S. J. et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet. Genomics 15, 201–209 (2005).
Devlin, B. & Risch, N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29, 311–322 (1995).
Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (Oxford, England) 21, 263–265 (2005).
Ganapathy, M. E., Brandsch, M., Prasad, P. D., Ganapathy, V. & Leibach, F. H. Differential recognition of beta-lactam antibiotics by intestinal and renal peptide transporters, PEPT 1 and PEPT 2. J. Biol. Chem. 270, 25672–25677 (1995).
Zhu, T., Chen, X. Z., Steel, A., Hediger, M. A. & Smith, D. E. Differential recognition of ACE inhibitors in Xenopus laevis oocytes expressing rat PEPT1 and PEPT2. Pharm. Res. 17, 526–532 (2000).
Rodriguez, L., Batlle, A., Di Venosa, G., MacRobert, A. J., Battah, S., Daniel, H. et al. Study of the mechanisms of uptake of 5-aminolevulinic acid derivatives by PEPT1 and PEPT2 transporters as a tool to improve photodynamic therapy of tumours. Int. J. Biochem. Cell Biol. 38, 1530–1539 (2006).
Becker, M. L., Visser, L. E., van Schaik, R. H., Hofman, A., Uitterlinden, A. G. & Stricker, B. H. Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response. Pharmacogenet. Genomics 20, 38–44 (2010).
Kerb, R., Brinkmann, U., Chatskaia, N., Gorbunov, D., Gorboulev, V., Mornhinweg, E. et al. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 12, 591–595 (2002).
Shu, Y., Leabman, M. K., Feng, B., Mangravite, L. M., Huang, C. C., Stryke, D. et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc. Natl Acad. Sci. USA 100, 5902–5907 (2003).
Sakata, T., Anzai, N., Shin, H. J., Noshiro, R., Hirata, T., Yokoyama, H. et al. Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions. Biochem. Biophys. Res. Commun. 313, 789–793 (2004).
Wang, Z. J., Yin, O. Q., Tomlinson, B. & Chow, M. S. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine. Pharmacogenet. Genomics 18, 637–645 (2008).
Tzvetkov, M. V., Vormfelde, S. V., Balen, D., Meineke, I., Schmidt, T., Sehrt, D. et al. The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin. Clin. Pharmacol. Ther. 86, 299–306 (2009).
Ho, E. S., Lin, D. C., Mendel, D. B. & Cihlar, T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383–393 (2000).
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K. et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl Acad. Sci. USA 97, 10483–10488 (2000).
Acknowledgements
This work was supported by a grant from Korea National Institute of Food and Drug Safety Evaluation (NIFDS) funded by Korea Food and Drug Administration (KFDA).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information accompanies the paper on Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Cheong, H., Kim, H., Na, H. et al. Screening of genetic variations of SLC15A2, SLC22A1, SLC22A2 and SLC22A6 genes. J Hum Genet 56, 666–670 (2011). https://doi.org/10.1038/jhg.2011.77
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/jhg.2011.77
Keywords
This article is cited by
-
Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health
Human Genetics (2022)
-
Genome-wide association study and genomic heritabilities for blood protein levels in Lori-Bakhtiari sheep
Scientific Reports (2021)
-
Tenofovir-associated kidney disease in Africans: a systematic review
AIDS Research and Therapy (2019)
-
Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population
European Journal of Clinical Pharmacology (2019)
-
Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population
Scientific Reports (2017)
